论文部分内容阅读
目的:研究超敏C反应蛋白(hsCRP)和脂蛋白(a)[Lp(a)]对急性心肌梗死行急诊冠状动脉介入治疗(PCI)患者预后的意义。方法:回顾我院自2007-01-2010-04因急性心肌梗死行急诊PCI的118例患者的hsCRP及Lp(a)水平,对hsCRP升高组和正常组以及Lp(a)升高组和正常组在住院期间心血管事件的发生率进行比较。结果:hsCRP升高组心血管事件发生率为52.9%,而hsCRP正常组心血管事件发生率为18.2%,两者比较差异具有统计学意义(P<0.05)。而Lp(a)升高组心血管事件发生率为35.3%,Lp(a)正常组事件发生率为46.4%,两者差异无统计学意义(P>0.05)。结论:hsCRP可作为急性心肌梗死行急诊PCI患者的近期预后的预测因子,而Lp(a)对这类患者的预后无预测作用。
Objective: To investigate the significance of hsCRP and lipoprotein (a) [Lp (a)] in the prognosis of patients undergoing emergency coronary intervention (PCI) with acute myocardial infarction. Methods: The hsCRP and Lp (a) levels in 118 patients with acute myocardial infarction (PCI) treated with acute myocardial infarction in our hospital from January 2007 to October 2010 were retrospectively analyzed. The changes of hsCRP and normal and Lp (a) The incidence of cardiovascular events in the normal group during hospitalization was compared. Results: The incidence of cardiovascular events in hsCRP elevated group was 52.9%, while the incidence of cardiovascular events in normal hsCRP group was 18.2%. There was significant difference between the two groups (P <0.05). The incidence of cardiovascular events in the Lp (a) elevated group was 35.3%, and the incidence of Lp (a) normal group events was 46.4%. There was no significant difference between the two groups (P> 0.05). Conclusion: hsCRP can be used as a predictor of recent prognosis in acute PCI patients with acute myocardial infarction, whereas Lp (a) has no predictive value in the prognosis of these patients.